Here’s Why Boeing (BA) is Among the 15 Most Promising Stocks to Buy Right Now
Boeing (BA) received two U.S. defense contract modifications in May 2026. On May 29, it was awarded up to $528.32M for a performance-based support contract for Air Force, Army, Navy and Marine Corps, due by Sept. 16, 2027. On May 27, Boeing won an $854.67M modification for four P-8A aircraft for FMS customers, due by Sept. 2030. Citi raised its BA price target to $260 from $256 and kept a Buy rating.
New defense contract scope and Citi’s raised price target provide near-term support for BA sentiment and order-book visibility.
Boeing received two large contract modifications (up to $528.32M and $854.67M) tied to P-8A aircraft and performance-based support, plus Citi reiterated Buy and raised its target.
Mildly positive bias; likely supports dip-buying, though broader risk remains tied to macro/Middle East and Boeing execution.
Background
The piece frames Boeing as a “promising stock” and highlights two May 2026 defense contract modifications plus a Citi target increase, while noting uncertainty around a broader market rebound tied to the Middle East conflict.
Why it matters
The contract modifications add measurable backlog/order scope (P-8A Lot 13 production/delivery and performance-based support), while the analyst target raise can reinforce valuation support. However, Citi’s caution implies the market may remain headline-sensitive.
Market relevance
Defense contract scope plus an analyst target increase are the actionable elements; they can support BA on dips, but the article itself doesn’t provide a new catalyst beyond these items.
Market effects
Supports aerospace/defense demand visibility via additional Navy/FMS aircraft scope and support-contract performance milestones.
Primarily US defense procurement read-through; limited direct regional spillover beyond defense primes.
FMS customer scope links US defense spending to international procurement flows, modestly reinforcing global defense order expectations.
Alternative perspectives
Contract awards may be incremental scope rather than a step-change in commercial recovery; stock reaction could fade if execution risk or macro headlines dominate.
The article doesn’t address delivery/execution timelines beyond contract completion dates, nor does it quantify margin impact or near-term cash flow effects.
Key entities
- companyThe Boeing Company
US defense and aerospace prime receiving multiple contract modifications and covered by Citi with a raised price target.
- analyst_firmCiti
Raised BA’s price target to $260 from $256 and maintained Buy, citing updated aerospace/defense models.
